bluebird bio, Inc. (BLUE)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
50.24-4.67 (-8.50%)
At close: 4:00 PM EDT
People also watch:
KITEJUNOAGIOCLVSESPR
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open54.79
Prev Close54.91
Bid46.10 x 100
Ask53.97 x 100
Day's Range49.95 - 57.00
52wk Range35.37 - 143.08
1y Target EstN/A
Market Cap1.87B
P/E Ratio (ttm)-8.99
Beta1.71
Volume1,543,809
Avg Vol (3m)942,923
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Capital Cube2 days ago

    ETF’s with exposure to bluebird bio, Inc. : August 23, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to bluebird bio, Inc. Here are 5 ETF’s with the largest exposure to BLUE-US. Comparing the performance and risk of bluebird bio, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cube13 days ago

    ETF’s with exposure to bluebird bio, Inc. : August 12, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to bluebird bio, Inc. Here are 5 ETF’s with the largest exposure to BLUE-US. Comparing the performance and risk of bluebird bio, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • bluebird bio, Inc. :BLUE-US: Earnings Analysis: Q2, 2016 By the Numbers : August 11, 2016
    Capital Cube14 days ago

    bluebird bio, Inc. :BLUE-US: Earnings Analysis: Q2, 2016 By the Numbers : August 11, 2016

    Categories: Yahoo Finance Click here to see latest analysis bluebird bio, Inc. reports financial results for the quarter ended June 30, 2016. We analyze the earnings along side the following peers of bluebird bio, Inc. – Celgene Corporation, BioMarin Pharmaceutical Inc., Ionis Pharmaceuticals, Inc., Acceleron Pharma Inc, Merck & Co., Inc., GlycoMimetics, Inc., Sangamo BioSciences, Inc. and Fibrocell ... Read more (Read more...)